Thomaspartners’s Novartis NVS Stock Holding History

Thomaspartners’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$311M	Buy	4,288,499 +123,163	+3%	+$9.38M	2.28%	13
2017 Q4	$313M	Buy	4,165,336 +123,643	+3%	+$9.33M	2.29%	14
2017 Q3	$311M	Buy	4,041,693 +86,842	+2%	+$6.56M	2.49%	11
2017 Q2	$296M	Buy	3,954,851 +215,065	+6%	+$15.2M	2.54%	8
2017 Q1	$249M	Buy	3,739,786 +370,830	+11%	+$24.7M	2.29%	14
2016 Q4	$220M	Buy	3,368,956 +271,749	+9%	+$17.6M	2.38%	14
2016 Q3	$219M	Buy	3,097,207 +172,531	+6%	+$12.6M	2.67%	4
2016 Q2	$216M	Buy	2,924,676 +1,268,154	+77%	+$87.6M	2.83%	2
2016 Q1	$108M	Buy	1,656,522 +212,485	+15%	+$14.5M	1.55%	43
2015 Q4	$111M	Buy	1,444,037 +62,745	+5%	+$4.98M	1.71%	37
2015 Q3	$114M	Buy	1,381,292 +17,328	+1%	+$1.54M	1.91%	27
2015 Q2	$120M	Buy	1,363,964 +16,481	+1%	+$1.51M	1.94%	24
2015 Q1	$119M	Buy	1,347,483 +76,444	+6%	+$6.78M	1.94%	27
2014 Q4	$106M	Buy	1,271,039 +83,380	+7%	+$6.91M	1.81%	32
2014 Q3	$100M	Buy	1,187,659 +72,194	+6%	+$5.84M	1.95%	20
2014 Q2	$90.5M	Buy	1,115,465 +115,459	+12%	+$9.08M	1.89%	25
2014 Q1	$76.2M	Buy	1,000,006 +126,280	+14%	+$9.2M	1.83%	23
2013 Q4	$62.9M	Buy	873,726 +147,505	+20%	+$10.3M	1.73%	29
2013 Q3	$49.9M	Buy	726,221 +114,592	+19%	+$7.58M	1.8%	15
2013 Q2	$43.3M	Buy	+611,629	New	+$39.8M	1.7%	23

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Thomaspartners's NVS Position: Q1 2018 in Review

Thomaspartners increased its Novartis (NVS) stake by 3% in Q1 2018, buying an estimated $9.38M and bringing the position to 4,288,499 shares worth $311M. The position accounts for 2.28% of the portfolio, ranked #13.

Thomaspartners first reported a position in NVS in Q2 2013 and has held it in 20 quarters since. The position peaked at $313M in Q4 2017. 1,012 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

Thomaspartners held 4,288,499 shares of Novartis worth $311M as of Q1 2018.
Thomaspartners bought 123,163 Novartis shares in Q1 2018, an estimated $9.38M.
Novartis made up 2.28% of Thomaspartners's portfolio in Q1 2018, its #13 holding.
Thomaspartners first reported a position in Novartis in Q2 2013 and has held it in 20 quarters since.
Thomaspartners's Novartis position peaked at $313M in Q4 2017.
1,012 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on Thomaspartners's 13F filing for Q1 2018, filed 2 May 2018.